Cantitate/Preț
Produs

Organotypic Models in Drug Development: Handbook of Experimental Pharmacology, cartea 265

Editat de Monika Schäfer-Korting, Silvya Stuchi Maria-Engler, Robert Landsiedel
en Limba Engleză Hardback – 26 mar 2021
This book provides latest findings in organotypic models in drug development and provides the scientific resonance needed in an emerging field of research in disciplines, such as molecular medicine, physiology, and pathophysiology. Today the research on human-based test systems has gained major interest and funding in the EU and the US has increased over the last years. Moreover, so-called 3R (reduce, replace, refine animal experiments) centres have been established worldwide. 

Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 129877 lei  38-44 zile
  Springer International Publishing – 29 mar 2022 129877 lei  38-44 zile
Hardback (1) 139147 lei  3-5 săpt.
  Springer International Publishing – 26 mar 2021 139147 lei  3-5 săpt.

Din seria Handbook of Experimental Pharmacology

Preț: 139147 lei

Preț vechi: 146471 lei
-5% Nou

Puncte Express: 2087

Preț estimativ în valută:
26630 27662$ 22120£

Carte disponibilă

Livrare economică 13-27 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030700621
ISBN-10: 3030700623
Pagini: 323
Ilustrații: VIII, 323 p. 70 illus., 37 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.68 kg
Ediția:1st ed. 2021
Editura: Springer International Publishing
Colecția Springer
Seria Handbook of Experimental Pharmacology

Locul publicării:Cham, Switzerland

Cuprins

Inflammatory skin disease models in vitro and in animals – predictability for drug development.- Neural In Vitro Models for Studying Substances Acting on the Central Nervous System.- Quality of commercial tissues Standardised Reconstructed Skin Models in Toxicology and Pharmacology: State of the Art and Future Development.- Human-Derived In Vitro Models Used for Skin Toxicity Testing Under REACh.- Disease Models: Lung models for testing drugs against inflammation and infection.- In Vitro Models of the Blood-Brain Barrier.- How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug Development.- The CAM Assay as an Alternative In Vivo Model for Drug Testing.- Organotypic Models in Drug Development “Tumor Models and Cancer Systems Biology for the Investigation of Anticancer Drugs and Resistance Development.- Tissue Engineering for Musculoskeletal Regeneration and Disease Modeling.- Immunocompetent human intestinal models in preclinical drug development.- EngineeredHeart Muscle Models in Phenotypic Drug Screens.

Textul de pe ultima copertă

This book provides latest findings in organotypic models in drug development and provides the scientific resonance needed in an emerging field of research in disciplines, such as molecular medicine, physiology, and pathophysiology. Today the research on human-based test systems has gained major interest and funding in the EU and the US has increased over the last years. Moreover, so-called 3R (reduce, replace, refine animal experiments) centres have been established worldwide.

Caracteristici

Maximizes the understanding of drug effects in human Broadens insights into drop-outs in drug development Maximizes reader insights into innovative techniques in drug testing based on human derived material